ESSA Pharma Inc (EPIX)

6.97 +0.02 (+0.29%) USD  |  NASDAQ  |  May 03, 16:00
6.97 0.00 (0.00%) After-Hours: 20:00
More

ESSA Pharma Cash and Short Term Investments (Quarterly): 142.12M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
December 31, 2023 142.12M
September 30, 2023 148.08M
June 30, 2023 152.47M
March 31, 2023 157.04M
December 31, 2022 163.07M
September 30, 2022 167.24M
June 30, 2022 174.60M
March 31, 2022 181.02M
December 31, 2021 189.20M
September 30, 2021 194.93M
June 30, 2021 202.26M
March 31, 2021 208.60M
December 31, 2020 74.50M
September 30, 2020 78.33M
June 30, 2020 36.48M
March 31, 2020 39.91M
December 31, 2019 45.93M
September 30, 2019 53.32M
June 30, 2019 4.874M
Date Value
March 31, 2019 8.598M
December 31, 2018 12.17M
September 30, 2018 14.83M
June 30, 2018 18.06M
March 31, 2018 21.69M
December 31, 2017 1.868M
September 30, 2017 3.957M
June 30, 2017 7.330M
March 31, 2017 12.62M
December 31, 2016 10.86M
September 30, 2016 8.985M
June 30, 2016 12.38M
March 31, 2016 15.93M
December 31, 2015 2.609M
September 30, 2015 1.579M
June 30, 2015 6.235M
March 31, 2015 10.44M
December 31, 2014 3.446M
September 30, 2014 3.70M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

4.874M
Minimum
Jun 2019
208.60M
Maximum
Mar 2021
127.05M
Average
152.47M
Median
Jun 2023

Cash and Short Term Investments (Quarterly) Benchmarks

Acasti Pharma Inc 25.11M
Aurinia Pharmaceuticals Inc 350.49M
Edesa Biotech Inc 4.268M
Lexaria Bioscience Corp 4.793M
Xenon Pharmaceuticals Inc 638.08M